2022
DOI: 10.1016/j.apjon.2022.100141
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning models for predicting survival in patients with ampullary adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…Specially, we found that RSF showed better predictive efficacy for short-term outcomes. Huang et al also obtained similar findings when using RSF and Cox regression to predict mortality in patients with pot-belly adenocarcinoma over 1–10 years [ 44 ], which may be due to the fact that short-term mortality risk is easier to predict because it only needs to consider serious events that occur in a shorter period of time, whereas long-term mortality risk is subject to more unknown and confounding factors. In addition, compared to traditional scores, we found that the RSF model had the best AUC performance (AUC = 0.875), followed by SAPSII, OASIS, SIRS and SOFA.…”
Section: Discussionmentioning
confidence: 71%
“…Specially, we found that RSF showed better predictive efficacy for short-term outcomes. Huang et al also obtained similar findings when using RSF and Cox regression to predict mortality in patients with pot-belly adenocarcinoma over 1–10 years [ 44 ], which may be due to the fact that short-term mortality risk is easier to predict because it only needs to consider serious events that occur in a shorter period of time, whereas long-term mortality risk is subject to more unknown and confounding factors. In addition, compared to traditional scores, we found that the RSF model had the best AUC performance (AUC = 0.875), followed by SAPSII, OASIS, SIRS and SOFA.…”
Section: Discussionmentioning
confidence: 71%
“…An ensemble of survival gradient-boosted trees for predicting individualized risk of MACCE at 2 years will be developed using the extreme gradient boosting (XGBoost) with survival embeddings framework 38,39 . Within this framework, the XGBoost algorithm will be used to build a binary classifier that identifies subjects (possibly right-censored) that experienced MACCE during follow-up by outputting a continuous score (from 0 to 1) which is interpreted as a risk score.…”
Section: Methodsmentioning
confidence: 99%
“…An ensemble of survival gradient-boosted trees for predicting individualized risk of MACCE at 2 years will be developed using the extreme gradient boosting (XGBoost) with survival embeddings framework. 38,39 Within this framework, the XGBoost algorithm will be used to build a binary classifier that identifies subjects (possibly right-censored) that experienced MACCE during follow-up by outputting a continuous score (from 0 to 1) which is interpreted as a risk score. During training the negative loglikelihood for the accelerated failure time model is minimized by sequentially fitting decision trees with different weights distributions over the data set subjects according to the performance of the previous estimators.…”
Section: Model Developmentmentioning
confidence: 99%
“…In recent years, deep learning (DL) and machine learning (ML) have been widely applied in mHealth [ 22 , 23 , 24 , 25 ]. In these studies, DL and ML models are not only used for diagnosing, estimating, mining, and delivering physiological signals, but also for preventing chronic diseases.…”
Section: Introductionmentioning
confidence: 99%